Novo Nordisk A/S Class B (NOVCb)

125.90
+5.06(+4.19%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    120.86 - 125.90

NOVCb Overview

Prev. Close
120.84
Day's Range
120.86-125.9
Revenue
-
Open
120.86
52 wk Range
82.53-130.8
EPS
-1.66
Volume
0
Market Cap
284.82B
Dividend (Yield)
1.26
(1.27%)
Average Volume (3m)
142
P/E Ratio
40.27
Beta
1.64
1-Year Change
44.7%
Shares Outstanding
2,258,087,613
Next Earnings Date
-
What is your sentiment on Novo Nordisk B?
or
Market is currently closed. Voting is open during market hours.

Novo Nordisk A/S Class B News

Novo Nordisk A/S Class B Analysis

Novo Nordisk A/S Class B Company Profile

Novo Nordisk A/S Class B Company Profile

Employees
52696
Market
Denmark
  • Type:Equity
  • Market:Germany
  • ISIN:DK0060534915
  • WKN:A1XA8R

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Read More

Analyst Price Target

Average962.22 (+2.20% Upside)
High1,200.00
Low540.00
Price941.50
No. of Analysts27
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyBuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuySellStrong Buy
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Buy